Cognitive Correlates of Substance Abuse - 11
Phase 4
- Conditions
- Amphetamine-Related Disorders
- Registration Number
- NCT00000346
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Brief Summary
The purpose of this study is to characterize the cognitive performance of methamphetamine abusers by comparing them with cocaine abusers and normal controls.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
M/F . Meet DSM-IV criteria for cocaine or methamphetamine dependence. Agree to conditions of the study and sign informed consent.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What cognitive deficits are associated with methamphetamine abuse compared to cocaine in NCT00000346?
How do dopamine transporter levels correlate with substance abuse severity in NCT00000346 participants?
What neuroimaging biomarkers distinguish methamphetamine from cocaine abuse in NIDA's study NCT00000346?
Are there specific executive function impairments in methamphetamine users that predict relapse risk?
How does prefrontal cortex dysfunction in substance abuse populations compare between stimulant types?
Trial Locations
- Locations (1)
Friends Research Institute
🇺🇸Los Angeles, California, United States
Friends Research Institute🇺🇸Los Angeles, California, United States